Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse ® G sTREM2 Assay for Research Use Only

Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse ® G…

Alzamend Neuro Soars on Breakthrough Trial News: Is This Biotech Stock a Hidden Gem?

Alright, folks, buckle up because we’re diving into the wild world of biotech stocks, and today,…

ClearPoint Neuro, Inc. (CLPT) Q1 2025 Earnings Call Transcript

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company…

ClearPoint Neuro: Fundamentals Continue To Strengthen

ClearPoint Neuro: Fundamentals Continue To Strengthen #ClearPoint #Neuro #Fundamentals #Continue #Strengthen

Phantom Neuro grabs $19M to help amputees put their phantom limbs to use

The science fiction trope of humans superpowered by computer and bionic implants is fast becoming a…

Alzamend Neuro CFO David Katzoff acquires $5,048 in common stock

Alzamend Neuro CFO David Katzoff acquires $5,048 in common stock#Alzamend #Neuro #CFO #David #Katzoff #acquires #common…

Alzamend Neuro director William B. Horne buys $4,851 in stock

Alzamend Neuro director William B. Horne buys $4,851 in stock#Alzamend #Neuro #director #William #Horne #buys #stock

ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen

ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen #ClearPoint #Neuro #Drug #Delivery #Prospects #Continue #Strengthen